Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product

TerminatedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 23, 2020

Study Completion Date

February 23, 2021

Conditions
B Cell LymphomasMultiple MyelomaSolid TumorHER-2 Protein Overexpression
Interventions
OTHER

ACTR T Cell Product

Trial Locations (16)

21201

University of Maryland, Baltimore

27710

Duke University Medical Center, Durham

30322

Emory University Winship Cancer Institute, Atlanta

32224

Mayo Clinic Florida, Jacksonville

37203

Tennessee Oncology - Nashville, Nashville

43210

Ohio State University, Columbus

46237

Indiana Bone and Marrow Transplantation, Indianapolis

53226

Medical College of Wisconsin, Milwaukee

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

60153

Loyola University, Maywood

75246

Baylor University Medical Center, Charles Sammons Cancer Center, Dallas

77030

MD Anderson Cancer Center, Houston

85054

Mayo Clinic Arizona, Phoenix

85234

Banner MD Anderson, Gilbert

06520

Yale University, New Haven

02111

Tufts Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Cogent Biosciences, Inc.

INDUSTRY